The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global CD115 Antibody Market Research Report 2024
Synopsis
CD115 (CSF-1R) is expressed on monocytes/macrophages, peritoneal exudate cells, plasmacytoid cells, dendritic cells, and osteoclasts. Background. CD115 antibody, clone AFS98, recognizes CD115, also known as mouse colony-stimulating factor 1 receptor (CSF-1R and macrophage colony-stimulating factor receptor (M-CSFR).
Global CD115 Antibody market is projected to reach US$ million in 2029, increasing from US$ million in 2022, with the CAGR of % during the period of 2023 to 2029. Influencing issues, such as economy environments, COVID-19 and Russia-Ukraine War, have led to great market fluctuations in the past few years and are considered comprehensively in the whole CD115 Antibody market research.
Key manufacturers engaged in the CD115 Antibody industry include Thermo Fisher Scientific, BosterBio, Bioss, BD Biosciences, RayBiotech, BioLegend, LifeSpan BioSciences, Bio-Rad and Antigenix America, etc. Among those manufacturers, the top 3 players guaranteed % supply worldwide in 2022.
When refers to consumption region, % volume of CD115 Antibody were sold to North America, Europe and Asia Pacific in 2022. Moreover, China, plays a key role in the whole CD115 Antibody market and estimated to attract more attentions from industry insiders and investors.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2023-2029), aims to help readers to get a comprehensive understanding of global CD115 Antibody market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
By Company
Thermo Fisher Scientific
BosterBio
Bioss
BD Biosciences
RayBiotech
BioLegend
LifeSpan BioSciences
Bio-Rad
Antigenix America
Leinco Technologies
Novus Biologicals
Tonbo Biosciences
ichorbio
R&D Systems
AffinityImmuno
Proteintech Group
GeneTex
Biobyt
Jingjie PTM BioLab
Segment by Type
Monoclonal
Polyclonal
Segment by Application
Immunochemistry (IHC)
Immunofluorescence (IF)
Immunoprecipitation (IP)
Western Blot (WB)
ELISA
Others
Consumption by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
Latin America
Mexico
Brazil
Argentina
Colombia
Middle East & Africa
Turkey
Saudi Arabia
UAE
The CD115 Antibody report covers below items:
Chapter 1: Product Basic Information (Definition, Type and Application)
Chapter 2: Manufacturers’ Competition Patterns
Chapter 3: Country Level Sales Analysis
Chapter 4: Product Type Analysis
Chapter 5: Product Application Analysis
Chapter 6: Manufacturers’ Outline
Chapter 7: Industry Chain, Market Channel and Customer Analysis
Chapter 8: Market Opportunities and Challenges
Chapter 9: Market Conclusions
Chapter 10: Research Methodology and Data Source
CD115 (CSF-1R) is expressed on monocytes/macrophages, peritoneal exudate cells, plasmacytoid cells, dendritic cells, and osteoclasts. Background. CD115 antibody, clone AFS98, recognizes CD115, also known as mouse colony-stimulating factor 1 receptor (CSF-1R and macrophage colony-stimulating factor receptor (M-CSFR).
Global CD115 Antibody market is projected to reach US$ million in 2029, increasing from US$ million in 2022, with the CAGR of % during the period of 2023 to 2029. Influencing issues, such as economy environments, COVID-19 and Russia-Ukraine War, have led to great market fluctuations in the past few years and are considered comprehensively in the whole CD115 Antibody market research.
Key manufacturers engaged in the CD115 Antibody industry include Thermo Fisher Scientific, BosterBio, Bioss, BD Biosciences, RayBiotech, BioLegend, LifeSpan BioSciences, Bio-Rad and Antigenix America, etc. Among those manufacturers, the top 3 players guaranteed % supply worldwide in 2022.
When refers to consumption region, % volume of CD115 Antibody were sold to North America, Europe and Asia Pacific in 2022. Moreover, China, plays a key role in the whole CD115 Antibody market and estimated to attract more attentions from industry insiders and investors.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2023-2029), aims to help readers to get a comprehensive understanding of global CD115 Antibody market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
By Company
Thermo Fisher Scientific
BosterBio
Bioss
BD Biosciences
RayBiotech
BioLegend
LifeSpan BioSciences
Bio-Rad
Antigenix America
Leinco Technologies
Novus Biologicals
Tonbo Biosciences
ichorbio
R&D Systems
AffinityImmuno
Proteintech Group
GeneTex
Biobyt
Jingjie PTM BioLab
Segment by Type
Monoclonal
Polyclonal
Segment by Application
Immunochemistry (IHC)
Immunofluorescence (IF)
Immunoprecipitation (IP)
Western Blot (WB)
ELISA
Others
Consumption by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
Latin America
Mexico
Brazil
Argentina
Colombia
Middle East & Africa
Turkey
Saudi Arabia
UAE
The CD115 Antibody report covers below items:
Chapter 1: Product Basic Information (Definition, Type and Application)
Chapter 2: Manufacturers’ Competition Patterns
Chapter 3: Country Level Sales Analysis
Chapter 4: Product Type Analysis
Chapter 5: Product Application Analysis
Chapter 6: Manufacturers’ Outline
Chapter 7: Industry Chain, Market Channel and Customer Analysis
Chapter 8: Market Opportunities and Challenges
Chapter 9: Market Conclusions
Chapter 10: Research Methodology and Data Source
Index1 CD115 Antibody Market Overview
1.1 Product Overview and Scope of CD115 Antibody
1.2 CD115 Antibody Segment by Type
1.2.1 Global CD115 Antibody Market Value Comparison by Type (2023-2029)
1.2.2 Monoclonal
1.2.3 Polyclonal
1.3 CD115 Antibody Segment by Application
1.3.1 Global CD115 Antibody Market Value by Application: (2023-2029)
1.3.2 Immunochemistry (IHC)
1.3.3 Immunofluorescence (IF)
1.3.4 Immunoprecipitation (IP)
1.3.5 Western Blot (WB)
1.3.6 ELISA
1.3.7 Others
1.4 Global CD115 Antibody Market Size Estimates and Forecasts
1.4.1 Global CD115 Antibody Revenue 2018-2029
1.4.2 Global CD115 Antibody Sales 2018-2029
1.4.3 Global CD115 Antibody Market Average Price (2018-2029)
1.5 Assumptions and Limitations
2 CD115 Antibody Market Competition by Manufacturers
2.1 Global CD115 Antibody Sales Market Share by Manufacturers (2018-2023)
2.2 Global CD115 Antibody Revenue Market Share by Manufacturers (2018-2023)
2.3 Global CD115 Antibody Average Price by Manufacturers (2018-2023)
2.4 Global CD115 Antibody Industry Ranking 2021 VS 2022 VS 2023
2.5 Global Key Manufacturers of CD115 Antibody, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of CD115 Antibody, Product Type & Application
2.7 CD115 Antibody Market Competitive Situation and Trends
2.7.1 CD115 Antibody Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest CD115 Antibody Players Market Share by Revenue
2.7.3 Global CD115 Antibody Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 CD115 Antibody Retrospective Market Scenario by Region
3.1 Global CD115 Antibody Market Size by Region: 2018 Versus 2022 Versus 2029
3.2 Global CD115 Antibody Global CD115 Antibody Sales by Region: 2018-2029
3.2.1 Global CD115 Antibody Sales by Region: 2018-2023
3.2.2 Global CD115 Antibody Sales by Region: 2024-2029
3.3 Global CD115 Antibody Global CD115 Antibody Revenue by Region: 2018-2029
3.3.1 Global CD115 Antibody Revenue by Region: 2018-2023
3.3.2 Global CD115 Antibody Revenue by Region: 2024-2029
3.4 North America CD115 Antibody Market Facts & Figures by Country
3.4.1 North America CD115 Antibody Market Size by Country: 2018 VS 2022 VS 2029
3.4.2 North America CD115 Antibody Sales by Country (2018-2029)
3.4.3 North America CD115 Antibody Revenue by Country (2018-2029)
3.4.4 United States
3.4.5 Canada
3.5 Europe CD115 Antibody Market Facts & Figures by Country
3.5.1 Europe CD115 Antibody Market Size by Country: 2018 VS 2022 VS 2029
3.5.2 Europe CD115 Antibody Sales by Country (2018-2029)
3.5.3 Europe CD115 Antibody Revenue by Country (2018-2029)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific CD115 Antibody Market Facts & Figures by Country
3.6.1 Asia Pacific CD115 Antibody Market Size by Country: 2018 VS 2022 VS 2029
3.6.2 Asia Pacific CD115 Antibody Sales by Country (2018-2029)
3.6.3 Asia Pacific CD115 Antibody Revenue by Country (2018-2029)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Southeast Asia
3.7 Latin America CD115 Antibody Market Facts & Figures by Country
3.7.1 Latin America CD115 Antibody Market Size by Country: 2018 VS 2022 VS 2029
3.7.2 Latin America CD115 Antibody Sales by Country (2018-2029)
3.7.3 Latin America CD115 Antibody Revenue by Country (2018-2029)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.7.7 Colombia
3.8 Middle East and Africa CD115 Antibody Market Facts & Figures by Country
3.8.1 Middle East and Africa CD115 Antibody Market Size by Country: 2018 VS 2022 VS 2029
3.8.2 Middle East and Africa CD115 Antibody Sales by Country (2018-2029)
3.8.3 Middle East and Africa CD115 Antibody Revenue by Country (2018-2029)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global CD115 Antibody Sales by Type (2018-2029)
4.1.1 Global CD115 Antibody Sales by Type (2018-2023)
4.1.2 Global CD115 Antibody Sales by Type (2024-2029)
4.1.3 Global CD115 Antibody Sales Market Share by Type (2018-2029)
4.2 Global CD115 Antibody Revenue by Type (2018-2029)
4.2.1 Global CD115 Antibody Revenue by Type (2018-2023)
4.2.2 Global CD115 Antibody Revenue by Type (2024-2029)
4.2.3 Global CD115 Antibody Revenue Market Share by Type (2018-2029)
4.3 Global CD115 Antibody Price by Type (2018-2029)
5 Segment by Application
5.1 Global CD115 Antibody Sales by Application (2018-2029)
5.1.1 Global CD115 Antibody Sales by Application (2018-2023)
5.1.2 Global CD115 Antibody Sales by Application (2024-2029)
5.1.3 Global CD115 Antibody Sales Market Share by Application (2018-2029)
5.2 Global CD115 Antibody Revenue by Application (2018-2029)
5.2.1 Global CD115 Antibody Revenue by Application (2018-2023)
5.2.2 Global CD115 Antibody Revenue by Application (2024-2029)
5.2.3 Global CD115 Antibody Revenue Market Share by Application (2018-2029)
5.3 Global CD115 Antibody Price by Application (2018-2029)
6 Key Companies Profiled
6.1 Thermo Fisher Scientific
6.1.1 Thermo Fisher Scientific Corporation Information
6.1.2 Thermo Fisher Scientific Description and Business Overview
6.1.3 Thermo Fisher Scientific CD115 Antibody Sales, Revenue and Gross Margin (2018-2023)
6.1.4 Thermo Fisher Scientific CD115 Antibody Product Portfolio
6.1.5 Thermo Fisher Scientific Recent Developments/Updates
6.2 BosterBio
6.2.1 BosterBio Corporation Information
6.2.2 BosterBio Description and Business Overview
6.2.3 BosterBio CD115 Antibody Sales, Revenue and Gross Margin (2018-2023)
6.2.4 BosterBio CD115 Antibody Product Portfolio
6.2.5 BosterBio Recent Developments/Updates
6.3 Bioss
6.3.1 Bioss Corporation Information
6.3.2 Bioss Description and Business Overview
6.3.3 Bioss CD115 Antibody Sales, Revenue and Gross Margin (2018-2023)
6.3.4 Bioss CD115 Antibody Product Portfolio
6.3.5 Bioss Recent Developments/Updates
6.4 BD Biosciences
6.4.1 BD Biosciences Corporation Information
6.4.2 BD Biosciences Description and Business Overview
6.4.3 BD Biosciences CD115 Antibody Sales, Revenue and Gross Margin (2018-2023)
6.4.4 BD Biosciences CD115 Antibody Product Portfolio
6.4.5 BD Biosciences Recent Developments/Updates
6.5 RayBiotech
6.5.1 RayBiotech Corporation Information
6.5.2 RayBiotech Description and Business Overview
6.5.3 RayBiotech CD115 Antibody Sales, Revenue and Gross Margin (2018-2023)
6.5.4 RayBiotech CD115 Antibody Product Portfolio
6.5.5 RayBiotech Recent Developments/Updates
6.6 BioLegend
6.6.1 BioLegend Corporation Information
6.6.2 BioLegend Description and Business Overview
6.6.3 BioLegend CD115 Antibody Sales, Revenue and Gross Margin (2018-2023)
6.6.4 BioLegend CD115 Antibody Product Portfolio
6.6.5 BioLegend Recent Developments/Updates
6.7 LifeSpan BioSciences
6.6.1 LifeSpan BioSciences Corporation Information
6.6.2 LifeSpan BioSciences Description and Business Overview
6.6.3 LifeSpan BioSciences CD115 Antibody Sales, Revenue and Gross Margin (2018-2023)
6.4.4 LifeSpan BioSciences CD115 Antibody Product Portfolio
6.7.5 LifeSpan BioSciences Recent Developments/Updates
6.8 Bio-Rad
6.8.1 Bio-Rad Corporation Information
6.8.2 Bio-Rad Description and Business Overview
6.8.3 Bio-Rad CD115 Antibody Sales, Revenue and Gross Margin (2018-2023)
6.8.4 Bio-Rad CD115 Antibody Product Portfolio
6.8.5 Bio-Rad Recent Developments/Updates
6.9 Antigenix America
6.9.1 Antigenix America Corporation Information
6.9.2 Antigenix America Description and Business Overview
6.9.3 Antigenix America CD115 Antibody Sales, Revenue and Gross Margin (2018-2023)
6.9.4 Antigenix America CD115 Antibody Product Portfolio
6.9.5 Antigenix America Recent Developments/Updates
6.10 Leinco Technologies
6.10.1 Leinco Technologies Corporation Information
6.10.2 Leinco Technologies Description and Business Overview
6.10.3 Leinco Technologies CD115 Antibody Sales, Revenue and Gross Margin (2018-2023)
6.10.4 Leinco Technologies CD115 Antibody Product Portfolio
6.10.5 Leinco Technologies Recent Developments/Updates
6.11 Novus Biologicals
6.11.1 Novus Biologicals Corporation Information
6.11.2 Novus Biologicals CD115 Antibody Description and Business Overview
6.11.3 Novus Biologicals CD115 Antibody Sales, Revenue and Gross Margin (2018-2023)
6.11.4 Novus Biologicals CD115 Antibody Product Portfolio
6.11.5 Novus Biologicals Recent Developments/Updates
6.12 Tonbo Biosciences
6.12.1 Tonbo Biosciences Corporation Information
6.12.2 Tonbo Biosciences CD115 Antibody Description and Business Overview
6.12.3 Tonbo Biosciences CD115 Antibody Sales, Revenue and Gross Margin (2018-2023)
6.12.4 Tonbo Biosciences CD115 Antibody Product Portfolio
6.12.5 Tonbo Biosciences Recent Developments/Updates
6.13 ichorbio
6.13.1 ichorbio Corporation Information
6.13.2 ichorbio CD115 Antibody Description and Business Overview
6.13.3 ichorbio CD115 Antibody Sales, Revenue and Gross Margin (2018-2023)
6.13.4 ichorbio CD115 Antibody Product Portfolio
6.13.5 ichorbio Recent Developments/Updates
6.14 R&D Systems
6.14.1 R&D Systems Corporation Information
6.14.2 R&D Systems CD115 Antibody Description and Business Overview
6.14.3 R&D Systems CD115 Antibody Sales, Revenue and Gross Margin (2018-2023)
6.14.4 R&D Systems CD115 Antibody Product Portfolio
6.14.5 R&D Systems Recent Developments/Updates
6.15 AffinityImmuno
6.15.1 AffinityImmuno Corporation Information
6.15.2 AffinityImmuno CD115 Antibody Description and Business Overview
6.15.3 AffinityImmuno CD115 Antibody Sales, Revenue and Gross Margin (2018-2023)
6.15.4 AffinityImmuno CD115 Antibody Product Portfolio
6.15.5 AffinityImmuno Recent Developments/Updates
6.16 Proteintech Group
6.16.1 Proteintech Group Corporation Information
6.16.2 Proteintech Group CD115 Antibody Description and Business Overview
6.16.3 Proteintech Group CD115 Antibody Sales, Revenue and Gross Margin (2018-2023)
6.16.4 Proteintech Group CD115 Antibody Product Portfolio
6.16.5 Proteintech Group Recent Developments/Updates
6.17 GeneTex
6.17.1 GeneTex Corporation Information
6.17.2 GeneTex CD115 Antibody Description and Business Overview
6.17.3 GeneTex CD115 Antibody Sales, Revenue and Gross Margin (2018-2023)
6.17.4 GeneTex CD115 Antibody Product Portfolio
6.17.5 GeneTex Recent Developments/Updates
6.18 Biobyt
6.18.1 Biobyt Corporation Information
6.18.2 Biobyt CD115 Antibody Description and Business Overview
6.18.3 Biobyt CD115 Antibody Sales, Revenue and Gross Margin (2018-2023)
6.18.4 Biobyt CD115 Antibody Product Portfolio
6.18.5 Biobyt Recent Developments/Updates
6.19 Jingjie PTM BioLab
6.19.1 Jingjie PTM BioLab Corporation Information
6.19.2 Jingjie PTM BioLab CD115 Antibody Description and Business Overview
6.19.3 Jingjie PTM BioLab CD115 Antibody Sales, Revenue and Gross Margin (2018-2023)
6.19.4 Jingjie PTM BioLab CD115 Antibody Product Portfolio
6.19.5 Jingjie PTM BioLab Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 CD115 Antibody Industry Chain Analysis
7.2 CD115 Antibody Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 CD115 Antibody Production Mode & Process
7.4 CD115 Antibody Sales and Marketing
7.4.1 CD115 Antibody Sales Channels
7.4.2 CD115 Antibody Distributors
7.5 CD115 Antibody Customers
8 CD115 Antibody Market Dynamics
8.1 CD115 Antibody Industry Trends
8.2 CD115 Antibody Market Drivers
8.3 CD115 Antibody Market Challenges
8.4 CD115 Antibody Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
